Cegedim Sa · EURONEXT:ALCGM

Cegedim Sa — Investor Day (January 2012)

59 slides from Cegedim Sa's investor day presentation, Jan 12, 2012

  1. Slide 1: Cegedim 2nd Annual Investor Summit

    Cegedim 2nd Annual Investor Summit January 12, 2012

  2. Slide 2: Welcome to Cegedim's 2nd Annual Investor Summit

    : Welcome to Cegedim’s a 2°*-Annual Investor Summit!

  3. Slide 3: Safe Harbour Statement

    Safe Harbour Statement This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). 1995) By their nature, nature forward-looking statements involve risk and uncertainty. Forward-looking statements repre

  4. Slide 4: Opening remarks

    Opening remarks Jan Eryk Umiastowski Chief Investment In estment Officer Head of Investor Relations | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 4 This document should not be distributed without Cegedim authorization – Copyright 2012

  5. Slide 5: Agenda

    Agenda ¼ Introduction C Cegedim di Yesterday Y t d anddT Today… d ¼ Focus on CRM solutions Franck Perales EMEA PreSales Director ¼ Focus on Compliance Solutions Guillaume Roussel VP, Compliance Solutions EMEA ¼ Focus Healthcare Software Eric Jarrousse Christophe Descamps Vice-President CHS Director

  6. Slide 6: Investor Questions

    Investor Questions / JPY/EUR D bt maturity Debt t it Debt level Market trend Business Model Dividend Policy Covenant g CAPEX Leverage G Growth th I Implementation l t ti Issues I Financing Acquisitions Growth Business Plan EBITDA Margin Economic Slowdown Li idit Liquidity Future Bond Cash allocation

  7. Slide 7: Why Healthcare Services? Why Cegedim? Why Now?

    Reasonable Investor Questions: ¼Why Healthcare Services? ¼Why Cegedim? ¼Why Now? | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 7 This document should not be distributed without Cegedim authorization – Copyright 2012

  8. Slide 8: Cegedim yesterday in 2006

    Cegedim yesterday in 2006 2006… | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 8 This document should not be distributed without Cegedim authorization – Copyright 2012

  9. Slide 9: Cegedim today

    …Cegedim Cegedim today… today FY2010 figures | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 9 This document should not be distributed without Cegedim authorization – Copyright 2012

  10. Slide 10: Cegedim evolution over 5 years

    …Cegedim Cegedim evolution over 5 years Between 2010 and 2006 | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 10 This document should not be distributed without Cegedim authorization – Copyright 2012

  11. Slide 11: Track record of steady revenue growth

    Track record of steady revenue growth… growth Including acquisitions €927m €874m €849m €753m €541m 2006A 2007A 2008A 2009A 2010A | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 11 This document should not be distributed without Cegedim authorization – Cop

  12. Slide 12: In line with the EBIT growth

    …in in line with the EBIT growth Including acquisitions €112m €107m €95m €97m €66m 2006A 2007A 2008A 2009A 2010A | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 12 This document should not be distributed without Cegedim authorization – Copyright 2012

  13. Slide 13: Creating value at every point in the healthcare system

    Creating g value at every y point in the healthcare system | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 13 This document should not be distributed without Cegedim authorization – Copyright 2012

  14. Slide 14: Cegedim offers a comprehensive set of solutions

    Cegedim g offers a comprehensive set of solutions Integrated solutions ¼ Competitor solutions are siloed and focus on specific segments key to addressing ƒ Unique presence in the healthcare industry issues of quality, ƒ Superior insights and understanding of the environment access and cost ƒ Signifi

  15. Slide 15: Cegedim activities focus on healthcare

    Cegedim activities focus on healthcare | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 15 This document should not be distributed without Cegedim authorization – Copyright 2012

  16. Slide 16: Comprehensive Solutions for Life Science Companies

    1. Comprehensive Solutions for Life Science Companies OneKey CRM Tools Strategic Data ƒ 69 countries covered ƒ Worldwide leader ƒ 36 years’ experience ƒ Constantly updated ƒ More than 200 200,000 000 users ƒ Over 50 global pharmaceutical ƒ Present in more than 80 countries companies as clients ƒ Cle

  17. Slide 17: Comprehensive Solutions for Healthcare Professional

    2. Comprehensive Solutions for Healthcare Professional Innovative clinical, financial and administrative solutions for healthcare professional | Group | CRM & Strategic Data | > Healthcare Professionals | Insurance & Services | Finance 17 This document should not be distributed without Cegedim autho

  18. Slide 18: Comprehensive Solutions for Payers

    3 Comprehensive Solutions for Payers 3. IT for healthcare insurers Flows and electronic payments Services ƒ Leader in France ƒ Leader in France ƒ Management Services ƒ Development in Morocco ƒ Payment management solutions ƒ Electronic Data Interchange (EDI) ƒ More than 30 million policy holders ƒ Mo

  19. Slide 19: Key Healthcare Stakeholders Face A Broad Set Of Challenges

    Key y Healthcare Stakeholders Face A Broad Set Of Challenges | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 19 This document should not be distributed without Cegedim authorization – Copyright 2012

  20. Slide 20: Key Drivers

    Key Drivers | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 20 This document should not be distributed without Cegedim authorization – Copyright 2012

  21. Slide 21: Significant Capital to Execute Our Strategy

    Significant g Capital to Execute Our Strategy | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 21 This document should not be distributed without Cegedim authorization – Copyright 2012

  22. Slide 22: Major Levers for Operating Margin Expansion

    Major j Levers for Operating g Margin g Expansion | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 22 This document should not be distributed without Cegedim authorization – Copyright 2012

  23. Slide 23: Experienced Management Team

    Experienced Management Team Jean-Claude Labrune Chantal Perusat Laurent Labrune Chairman and CEO Director of Human Resources CRM 43 y years 30 yyears 17 y years Pierre Marucchi Anna Guillaume Bruno Sarfati Managing Director Global Legal Counsel Strategic Data 28 years 8 years 17 years Sandrine Debro

  24. Slide 24: Why Healthcare Services? Why Cegedim? Why Now?

    Reasonable Investor Questions: ¼Why Healthcare Services? ¼Why Cegedim? ¼Why Now? | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 24 This document should not be distributed without Cegedim authorization – Copyright 2012

  25. Slide 25: Cegedim is well positioned for long-term growth

    Cegedim g is well positioned for long-term g growth ¼ Healthcare is an attractive and stable industry ¼ Cegedim has industry leading positions in healthcare services, creating value for our customers through unique and comprehensive offerings ¼ All businesses are poised for continued long-term growt

  26. Slide 26: Areas of investor interest

    Areas of investor interest Our capability Operating actions – Diverse business model – Scenario S i planning l i Macro – Lots of liquidity – Ongoing actions – Prepared for market change – Maturity extended – Focus on cash generation Debt – Access to different sources of financing – Balanced approach

  27. Slide 27: Investor relation Policy

    Investor relation Policy | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 27 This document should not be distributed without Cegedim authorization – Copyright 2012

  28. Slide 28: An Award Winning Company

    An Award Winning Company The Grand Prix for Financial Transparency ¼ Grand Prix of Transparency “The prize have been awarded in recognition for the best practices in regulated financial reporting. It pay tribute to the listed French companies that have demonstrated their ability to make use of the b

  29. Slide 29: An Award Winning Company

    An Award Winning Company IDC Ph Pharmaceutical ti l SFA MarketScape M k tS ¼ What IDC Says About Cegedim “Cegedim’s application ranks among the best available for breadth of functionality, user interface and functional flexibility…” “Cegedim offers a complete line of deployment options (on-premise,

  30. Slide 30: Focus on CRM solutions

    Focus on CRM solutions Franck Perales EMEA PreSales Director | Group | > CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 30 This document should not be distributed without Cegedim authorization – Copyright 2012

  31. Slide 31: Mobile Intelligence iPad

    Mobile Intelligence 7 iPad ¼ Identify - Healthcare Professional ¼ Prepare - Pre Call ¼ Execute - Call ¼ Capture - Post Call ¼ Follow up - Activity ¼ Analyze - Performance | Group | > CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 31 This document should not be distr

  32. Slide 32: Mobile Intelligence iPad

    Mobile Intelligence 7 iPad ¼ Identify ƒ Quick search, action plan, routes… ƒ Follow my planner ¼ Prepare ƒ Consult HCP card ƒ Navigate Essential, Rating, Call History ¼ Execute ƒ MultiMedia Presentation ƒ Medical Inquiry + Signature ¼ Capture ƒ Call report ¼ Follow Up ƒ Edit a task ƒ Task T k manage

  33. Slide 33: Focus on Compliance solutions

    Focus on Compliance solutions Guillaume Roussel VP Compliance VP, C li Solutions S l ti EMEA | Group | > CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 33 This document should not be distributed without Cegedim authorization – Copyright 2012

  34. Slide 34: Global Compliance Context

    Global Compliance Context ¼ Similarities between the U.S. and Europe for the development & enforcement of regulations and industry guidance to streamline interactions with HCPs ƒ Industry Codes of Conduct ƒ Payments to Healthcare Providers ƒ Conflict of Interest (FCPA, (FCPA UK bribery Act ) ¼ Major

  35. Slide 35: Current Global Regulatory Trends

    Current Global Regulatory g y Trends EMEA / North America Type of Regulations/ Company’s Scope Sanctions/ Penalties Guidance obligations State Laws Promotional spend p reporting p g U.S. Law Federal Law Promotional spend reporting U.S. Law (PPACA 6002) and public disclosure ABPI Speaker, p , consult

  36. Slide 36: The On-going Operational Cycle of Transparency

    The On-going g g Operational Cycle y of Transparency Data Posting Evaluation ƒSpend Data Positing on the Internet ƒOngoing Transparency regulation based on regulatory requirements monitoring and update ƒRegulation guidance and best practices Comply with Align your regulations Processes Alignment Spe

  37. Slide 37: Supporting Life Sciences Performance

    Supporting Life Sciences Performance Customer CRM Software Professional Business Marketing Database Solutions & Services Intelligence Solutions Services KNOW PERFORM SUPPORT EVALUATE COMPLY PROMOTE Your Customers Based on your Users & Systems Effectiveness of Regulatory Your brand business processes

  38. Slide 38: The Cegedim Global Solution

    The Cegedim Global Solution Internal app ERP (SAP) Transparency Disclosure Automatic T&E integration (Concur) CRM Alert system Integration, validation and Spend data to covered recipient p spend g data management Predefined for reporting acknowledgement Travel Customized Agencies reporting Spend dat

  39. Slide 39: Cegedim Compliance Solution for Transparency

    C Cegedim C Compliance S Solution ffor Transparency | Group | > CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 39 This document should not be distributed without Cegedim authorization – Copyright 2012

  40. Slide 40: Focus Healthcare Software

    Focus Healthcare Software Eric Jarrousse Vice-President CHS Christophe Descamps Director RESIP | Group | CRM & Strategic Data | > Healthcare Professionals | Insurance & Services | Finance 40 This document should not be distributed without Cegedim authorization – Copyright 2012

  41. Slide 41: A new Agreement signed by Unions and Social Security in 2011

    A new Agreement signed by Unions and Social Security in 2011 : a real « boost » for medical software 41 This document should not be distributed without Cegedim authorization – Copyright 2012

  42. Slide 42: The Payment for Performance (P4P)

    The Payment for Performance (P4P) ¼ An international tender ƒ USA, Obama Plan: PQRI (Physician Quality Reporting Initiative) and « Meaningful Use » Î US doctors will have more than 250 indicators to follow daily ƒ Belgium: certification for HealthCare Software and e-Health initiative (e-prescribing)

  43. Slide 43: Indicators in France (1/2)

    Indicators in France (1/2) ¼ 1. Practice organization INDICATORS (5) # points* Equipment allowing Electronic Medical Records and capture of clinical 75 informations for individual monitoring g for each p patient Use of a certified Prescribing software 50 Equipment allowing electronic billing (sesam-

  44. Slide 44: Indicators in France (2/2)

    Indicators in France (2/2) ¼ 2. Quality of medical Practice INDICATEURS (24) Nb points Following of chronic diseases: - diabetis ((8 indicators)) 250 - High blood pressure (1 indicator) Prevention : - Flu (2 indicators) - Breast Cancer (1 indicator) - Vasodilatators (1 indicator) 250 - Benzodiazepin

  45. Slide 45: A few examples (from 24 in group #2)

    A few examples (from 24 in group # 2) 1. 80% of diabetics must have a well well-balanced balanced blood sugar (HbA1c < 7,5%) 2. 75% of diabetics with high blood pressure must also have a specifie treatment against cholesterol (statins) 3. 60% of hypertensive patients must have a well-balanced pressu

  46. Slide 46: In summary

    In summary ¼ For a doctor (French and others), the practical application of this new agreement is impossible unless he is equipped with: ƒ a Medical Software dealing with structured data ƒ and an exhaustive and certified Drug Database | Group | CRM & Strategic Data | > Healthcare Professionals | Ins

  47. Slide 47: Conclusion

    Conclusion ¼ To date, 30000 French doctors do not have tools to apply this agreement: ƒ Young doctors ƒ Specialists with multiple places of practice ¼ or seek to maintain a light equipment: ƒ Larger Group practice ƒ Future Homes and Health Centers ¼ For these, and many others, CLM breaks the new wit

  48. Slide 48: Drug Database

    ¼ Founded in 1985 ¼ Drug Database ¼ The first approved by the Health Authority (HAS) ¼ No paper version ¼ Integrated in Medical Software ¼ Customers : 15 15.000 000 Doctors Doctors, 2 2.500 500 Retirement Homes Homes, 17 17.000 000 Paramedics Paramedics, 9.000 Pharmacists, 1.500 Hospitals and Clinic

  49. Slide 49: Drug database features

    ¼ Official sources : AFSSAPS, EMA, HAS, INCA and JO ¼ Author structuring information ¼ Exhaustive ¼ Independent ¼ Orders and Deliverances Control : ƒ Interactions, Cntraindications, Precautions of Use, Allergies, Pregnancy, Lactation, Side Effects… ƒ Fight effectively against Iatrogenic ¼ Daily Upda

  50. Slide 50: 13,000 Drugs

    13 000 Drugs 13,000 | Group | CRM & Strategic Data | > Healthcare Professionals | Insurance & Services | Finance 50 This document should not be distributed without Cegedim authorization – Copyright 2012

  51. Slide 51: 100,000 Non Drug Products

    100 000 Non Drug Products 100,000 | Group | CRM & Strategic Data | > Healthcare Professionals | Insurance & Services | Finance 51 This document should not be distributed without Cegedim authorization – Copyright 2012

  52. Slide 52: 100,000 Non Drug Products

    100 000 Non Drug Products 100,000 | Group | CRM & Strategic Data | > Healthcare Professionals | Insurance & Services | Finance 52 This document should not be distributed without Cegedim authorization – Copyright 2012

  53. Slide 53: www.bcbdexther.fr

    www.bcbdexther.fr | Group | CRM & Strategic Data | > Healthcare Professionals | Insurance & Services | Finance 53 This document should not be distributed without Cegedim authorization – Copyright 2012

  54. Slide 54: Closing remarks

    Closing remarks Jan Eryk Umiastowski Chief Investment In estment Officer Head of Investor Relations | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 54 This document should not be distributed without Cegedim authorization – Copyright 2012

  55. Slide 55: Cegedim

    Cegedim | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 55 This document should not be distributed without Cegedim authorization – Copyright 2012

  56. Slide 56: Cegedim is confident in its future growth potential

    Cegedim g is confident in its future growth potential based on: | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 56 This document should not be distributed without Cegedim authorization – Copyright 2012

  57. Slide 57: Cegedim tomorrow

    Cegedim tomorrow… tomorrow | > Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | Finance 57 This document should not be distributed without Cegedim authorization – Copyright 2012

  58. Slide 58: 2012 Finance agenda

    2012 Finance agenda 9 | Group | CRM & Strategic Data | Healthcare Professionals | Insurance & Services | > Finance 58 This document should not be distributed without Cegedim authorization – Copyright 2012

  59. Slide 59: We welcome your questions and comments

    it. . w=, cegedim We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer Head of Investor Relations investor.relations@cegedim.com www.cegedim.com/finance TEL: +33 (Q) 1 49 09 33 36

Cegedim — Investor Day (January 2012) on 6ix